See previous post here. Novopharm is the #2 Canadian generic by sales in 2007; ratiopharm was the #4.
Article in NY Times is here. Price: $5 billion.
The Pharmaceutical Patent Cliff Has a Timetable — And It’s Public
-
IP Organiser’s recently compiled record of every pharmaceutical patent term
extension granted in Australia maps roughly 1,600 extended patents across
850 p...
3 days ago
No comments:
Post a Comment